Kim Young-Il, Lee Jong Yeul, Kim Chan Gyoo, Choi Il Ju
Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
Helicobacter. 2025 Jul-Aug;30(4):e70068. doi: 10.1111/hel.70068.
Helicobacter pylori (Hp) infection is associated with metachronous gastric cancer (GC) after endoscopic submucosal dissection resection (ESD) in patients with early GC (EGC), but this association has not been well investigated in elderly patients. This study investigated whether Hp infection status was associated with metachronous GC after ESD in patients aged ≥ 75 years.
This retrospective study involved 298 EGC patients aged ≥ 75 years who underwent ESD. The Hp-negative group (n = 233) included patients with negative or eradicated Hp infection, whereas the Hp-positive group (n = 65) included patients with persistently positive infection or failed eradication. The primary outcome was metachronous GC occurring at ≥ 1 year after ESD.
The median patient age was 78 years (interquartile range [IQR]: 76-80 years). During a median follow-up of 4.4 years (IQR: 2.9-5.9 years), metachronous GC occurred in 16 (6.9% [16/233], 16.3 cases/1000 person-year) and 10 (15.4% [10/65], 37.5 cases/1000 person-year) patients in the Hp-negative and Hp-positive groups, respectively. The incidence of metachronous cancer was higher in the Hp-positive group than in the Hp-negative group (p = 0.035, log-rank test). In a multivariate analysis, persistent Hp infection was an independent risk factor for metachronous GC (age- and sex-adjusted hazard ratio, 2.33; 95% CI: 1.05-5.17).
Persistent H. pylori infection status was associated with a higher risk of metachronous GC, and H. pylori treatment needs to be provided in elderly patients aged ≥ 75 years and older with EGC undergoing ESD.
在早期胃癌(EGC)患者中,幽门螺杆菌(Hp)感染与内镜黏膜下剥离术(ESD)切除术后的异时性胃癌(GC)相关,但在老年患者中这种关联尚未得到充分研究。本研究调查了年龄≥75岁的患者在ESD术后Hp感染状态是否与异时性GC相关。
这项回顾性研究纳入了298例年龄≥75岁且接受ESD的EGC患者。Hp阴性组(n = 233)包括Hp感染阴性或已根除的患者,而Hp阳性组(n = 65)包括持续感染阳性或根除失败的患者。主要结局是ESD术后≥1年发生的异时性GC。
患者的中位年龄为78岁(四分位间距[IQR]:76 - 80岁)。在中位随访4.4年(IQR:2.9 - 5.9年)期间,Hp阴性组和Hp阳性组分别有16例(6.9%[16/233],16.3例/1000人年)和10例(15.4%[10/65],37.5例/1000人年)患者发生异时性GC。Hp阳性组异时性癌症的发生率高于Hp阴性组(p = 0.035,对数秩检验)。在多变量分析中,持续的Hp感染是异时性GC的独立危险因素(年龄和性别调整后的风险比为2.33;95%CI:1.05 - 5.17)。
持续的幽门螺杆菌感染状态与异时性GC的较高风险相关,对于年龄≥75岁且接受ESD的EGC老年患者需要进行幽门螺杆菌治疗。